Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone-sensitive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)
暂无分享,去创建一个
H. Tsuda | M. Kurosumi | Tsuyoshi Saito | T. Tabei | Kenichi Inoue | H. Takei | Kazuhiko Sato | K. Okubo | J. Koh | Suemasu